Ukraine had alleged that a Russian missile directly hit the site and accused Moscow of “deliberately” targeting Indian ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient ...

Key Takeaways Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released Phase 3 trial results ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a ...

They're a group of over-the-counter meds that are arguably the most trusted to soothe aches and fever—and two major stores ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic collaboration. Purdue University is on the forefront of Pharma 4.0 by partnering ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.